CLINICAL TRIALS

Streamlining clinical trials and enrollment with voice biomarker technology.

Canary Speech coordinates all supply chain stakeholders to streamline clinical trials. Our technology allows non-invasive, cost-effective data collection to track patient outcomes at scale. We make participation more accessible, convenient, and sustainable for patients, clinicians, and sponsors.

76%

76% of 200+ polled clinical trial sponsors stated they conducted most or all of their patient monitoring remotely.

9 out of 10

9 out of 10 trials require the original timeline to be doubled in order to meet enrollment goals.

92.7%

92.7% of oncology patients state it’s important to speak with clinical researchers before joining a trial.

Clinical trials are no longer bound by processing times to collect participant data. Our technology gives research teams access to objective, actionable data immediately. Trial participants provide a 20-second audio sample and our system returns an analysis in less than a minute.

The ability to use voice to identify MS would offer a quick, non-invasive screening tool, enabling us to deliver faster care to patients. We’re thrilled to collaborate with Canary Speech and leverage their innovative technology in this pioneering study.

Dr. Timothy West

Neurologist with Intermountain Health